UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 07/2020, Volume 84, Issue 3, pp. 235 - 241
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Cytochrome P-450 CYP3A Inducers - therapeutic use | Humans | Mothers | Cyclopropanes - therapeutic use | Cytochrome P-450 CYP2B6 Inducers - therapeutic use | Young Adult | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | Reverse Transcriptase Inhibitors - therapeutic use | Anti-Retroviral Agents - therapeutic use | Cytochrome P-450 CYP2C19 Inhibitors - therapeutic use | Emtricitabine - therapeutic use | Cytochrome P-450 CYP2C9 Inhibitors - therapeutic use | Tenofovir - therapeutic use | Risk Factors | Piperazines - therapeutic use | Benzoxazines - therapeutic use | Alkynes - therapeutic use | Pregnancy | Oxazines - therapeutic use | Botswana | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Infections - drug therapy | Pyridones - therapeutic use | Infectious Disease Transmission, Vertical - prevention & control | Drug Combinations | Emtricitabine | Antiretroviral drugs | Infants | Exposure | Ribonucleic acid--RNA | Efavirenz | Antiretroviral therapy | Confidence intervals | Tenofovir | Databases | Disease transmission | Surveillance | Health surveillance | Antiretroviral agents | Human immunodeficiency virus--HIV | DNA testing | Deoxyribonucleic acid--DNA | Index Medicus | AIDS/HIV
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2012, Volume 142, Issue 6, pp. 1324 - 1334.e3
Gastroenterology and Hepatology | Drug Interaction | HCV | Treatment | HIV | Liver Disease | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recombinant Proteins - therapeutic use | Coinfection | Antiviral Agents - pharmacokinetics | HIV Infections - epidemiology | Humans | Hepatitis C, Chronic - etiology | Male | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Tenofovir | Deoxycytidine - therapeutic use | Drug Interactions | Homosexuality, Male | Adenine - therapeutic use | Lamivudine - therapeutic use | Anti-HIV Agents - therapeutic use | Dideoxynucleosides - therapeutic use | Hepatitis C, Chronic - epidemiology | Drug Therapy, Combination | Raltegravir Potassium | Substance Abuse, Intravenous - complications | Emtricitabine | Liver Diseases - virology | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Drug Administration Schedule | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Liver Diseases - prevention & control | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Pyrrolidinones - therapeutic use | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Disease Progression | Proline - therapeutic use | HIV Infections - etiology | Liver Cirrhosis - virology | Antiviral Agents - adverse effects | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Antiviral agents | Medical colleges | Care and treatment | Liver diseases | Comorbidity | Drug interactions | Mortality | Development and progression | Biological response modifiers | HIV (Viruses) | Hepatitis | Protease inhibitors | Proteases | Hepatitis C virus | Hepatitis C | Health aspects | HIV infection | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2015, Volume 15, Issue 7, pp. 775 - 784
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | HIV-1 | Humans | Middle Aged | Male | RNA, Viral - blood | Viral Load | Oligopeptides - therapeutic use | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Drug Therapy, Combination - adverse effects | Adenine - therapeutic use | Lamivudine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Pyridines - therapeutic use | Emtricitabine | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | HIV Infections - virology | HIV Protease Inhibitors - therapeutic use | Drug Therapy, Combination - methods | HIV Infections - drug therapy | Zidovudine - therapeutic use | Drug Substitution | Deoxycytidine - analogs & derivatives | Studies | Antiretroviral drugs | Heart attacks | Protease inhibitors | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Clinical trials | Infections | Mutation | Drug therapy | Failure | Cost control | Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 7/2013, Volume 208, Issue 1, pp. 32 - 39
T lymphocytes | HIV/AIDS | Antiretrovirals | Infectious diseases | RNA | HIV | Drug evaluation | AIDS | Photographs | HIV 1 | Virology | cobicistat | pharmacoenhancer | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Thiazoles - therapeutic use | Oligopeptides - therapeutic use | Anti-HIV Agents - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Drug Therapy, Combination | Pyridines - therapeutic use | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Organophosphonates - therapeutic use | Ritonavir - administration & dosage | HIV-1 - drug effects | Deoxycytidine - administration & dosage | Treatment Outcome | HIV Protease Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Adenine - administration & dosage | Organophosphonates - administration & dosage | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Carbamates - therapeutic use | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Research | Drug therapy | HIV infection | Patient outcomes | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 10/2015, Volume 212, Issue 8, pp. 1241 - 1249
Journal Article
AIDS (London), ISSN 0269-9370, 01/2015, Volume 29, Issue 2, pp. 167 - 174
Integrase | Subgroup | Treatment efficacy | Treatment-naive | Dolutegravir | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | HIV-1 | Coinfection | Humans | Male | Viral Load | Tenofovir | Clinical Trials, Phase III as Topic | Deoxycytidine - therapeutic use | Adenine - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Dideoxynucleosides - therapeutic use | Retrospective Studies | Antiretroviral Therapy, Highly Active - methods | Raltegravir Potassium | Emtricitabine | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Pyrrolidinones - therapeutic use | Treatment Outcome | CD4 Lymphocyte Count | HIV Protease Inhibitors - therapeutic use | Randomized Controlled Trials as Topic | Regression Analysis | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Integrase Inhibitors - therapeutic use | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Drug Combinations | Index Medicus | AIDS/HIV | treatment-naive | Clinical Science | subgroup | dolutegravir | integrase | treatment efficacy
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2012, Volume 56, Issue 5, pp. 2305 - 2313
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Genomics | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | HIV Reverse Transcriptase - genetics | Reverse Transcriptase Inhibitors - administration & dosage | Thymidine - therapeutic use | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Tenofovir | Thymidine - administration & dosage | Adenine - therapeutic use | HIV-1 - isolation & purification | Anti-HIV Agents - therapeutic use | Dideoxynucleosides - therapeutic use | Nucleosides - genetics | Reverse Transcriptase Inhibitors - therapeutic use | Dideoxynucleosides - administration & dosage | Drug Resistance, Multiple, Viral - drug effects | Adenine - analogs & derivatives | Drug Resistance, Multiple, Viral - genetics | Organophosphonates - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Genotype | HIV-1 - genetics | Adenine - administration & dosage | Organophosphonates - administration & dosage | Phenotype | Algorithms | Least-Squares Analysis | HIV Infections - drug therapy | Zidovudine - therapeutic use | Mutation | Index Medicus | nucleosides | RNA-directed DNA polymerase | tenofovir | Abacavir | Data processing | Thymidine | Drug resistance | Statistics | Antiviral Agents
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2013, Volume 62, Issue 5, pp. 483 - 486
Emtricitabine | Tenofovir | Treatment-naive | HIV | Elvitegravir | Efavirenz | Antiretroviral therapy | Cobicistat | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Microbiology | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Virology | Confidence Intervals | Humans | Male | RNA, Viral - blood | Alanine Transaminase - blood | Thiazoles - therapeutic use | Oligopeptides - therapeutic use | Deoxycytidine - therapeutic use | Adenine - therapeutic use | HIV-1 - isolation & purification | Quinolones - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Pyridines - therapeutic use | HIV Infections - blood | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | HIV Infections - virology | HIV-1 - genetics | Bilirubin - blood | Bone Density - drug effects | Aspartate Aminotransferases - blood | Triglycerides - blood | Creatinine - blood | HIV Infections - drug therapy | Carbamates - therapeutic use | Deoxycytidine - analogs & derivatives | Drug Combinations | Clinical trials | Antiretroviral drugs | Drug therapy | Drug testing | Human immunodeficiency virus--HIV | Indexing in process | Index Medicus | AIDS/HIV
Journal Article